Abstract:Background: In East Asia, the number of patients with adenocarcinoma, especially those presenting with ground-glass nodules (GGNs), is gradually increasing. Family aggregation of pulmonary GGNs is not uncommon; however, genetic predisposition in these patients remains poorly understood and identification of genes involved in the cause of these early-stage lung cancers might contribute to understanding of the underlying mechanisms and potential prevention strategies. Methods: Fifty patients with early-stage lung adenocarcinoma (LUAD) presenting as GGNs and a firstdegree family history of lung cancer (FHLC) from 34 independent families were enrolled into this study. Germline mutations of these patients were analyzed with whole exome sequencing (WES) and compared with age- and sex-matched 39 patients with sporadic lung cancer and 689 local healthy people. We used a stepwise variant filtering strategy, gene-based burden testing, and enrichment analysis to investigate rare but potentially pathogenic heritable mutations. Somatic tumor mutations were analyzed to consolidate germline findings. Results: In total, 1,571 single nucleotide variants (SNVs) and 238 frameshifts with a minor allele frequency (MAF) <0.01, which were rare, recurrent, and potentially damaging candidates, were finally identified through the filtering in the GGN cohort. Pathway analysis showed the extracellular matrix to be the top dysregulated pathway. Gene-based burden testing of these highly disruptive risk-conferring heritable variants showed that MSH5 [odds ratio (OR), 9.28, 95% confidence interval (CI): 2.49- 35.87], MMP9 (OR, 8.11, 95% CI: 2.22-28.43), and CYP2D6 (OR, 8.09, 95% CI: 2.68-24.92) were significantly enriched in our cohort (P<0.05). The number of rare damaging germline variants in non-smoking patients was significantly higher than that of smoking-affected patients (Spearman's.=-0.39, P=0.02). Conclusions: Heritable, potentially deleterious, and rare candidate variants of MSH5, MMP9 and CYP2D6 were significantly associated with early-stage LUAD presenting with GGNs. Nonsmoking patients likely have a higher genetic predisposition to this type of cancer than smoking-affected patients. These results have extended our understanding of the underlying mechanisms of early-stage LUAD.

Interaction Analysis Between Germline Susceptibility Loci and Somatic Alterations in Lung Cancer.

SNP Rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

Genetic Variations in Cancer-Related Significantly Mutated Genes and Lung Cancer Susceptibility.

Relationship Between Polymorphisms of DNA Repair Gene ERCC1 and Susceptibility to Lung Cancer

Combined analysis with copy number variation identifies risk loci in lung cancer.

Data from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Pathogenic Germline Mutation Profile In Chinese Lung Cancers And Related-Driver Mutation Pattern.

Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing

Genomic features of lung cancer patients harboring germline mutations associated with hereditary cancer syndromes.

Integrating Expression-Related SNPs into Genome-Wide Gene- and Pathway-Based Analyses Identified Novel Lung Cancer Susceptibility Genes.

Identification of Heritable Rare Variants Associated with Early-Stage Lung Adenocarcinoma Risk

A large-scale genome-wide gene-gene interaction study of lung cancer susceptibility in Europeans with a trans-ethnic validation in Asians

A Cross-Tissue Transcriptome-Wide Association Study Identifies Novel Susceptibility Genes for Lung Cancer in Chinese Populations.

Genome-wide Gene-Smoking Interaction Study Identified Novel Susceptibility Loci for Non-Small Cell Lung Cancer in Chinese Populations.

Systematic Analyses of Regulatory Variants in DNase I Hypersensitive Sites Identified Two Novel Lung Cancer Susceptibility Loci

rs66651343 and rs12909095 confer lung cancer risk by regulating CCNDBP1 expression

C8-04: Genetic Polymorphisms in Cell Cycle Control Pathways and Lung Cancer Risk

Polymorphisms and Rare Variants Identified by Next-Generation Sequencing Confer Risk for Lung Cancer in Han Chinese Population.

Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls

An Investigation of the Association of Genetic Susceptibility Risk with Somatic Mutation Burden in Breast Cancer